Print
Email
Print Edition StoriesThursday, August 13, 2009
Thermo Fisher grant program to award RNAi reagents
By Mass High Tech staff
MHT's Efrain Viscarolasaga: Tech companies may have to wait for stimulus funds
MHT's Marc Songini: Researchers focus on macular degeneration
MHT's Marc Songini: Mass. bio firms prep for lifting of stem cell ban
Thermo Fisher Scientific Inc., the Waltham-based instrumentation and research products company, has created a grant program that will award researchers studying genes with more than $400,000 in RNA-interference reagents.
The program, open to both academic and commercial scientists, will recognize five projects with reagents from Thermo Scientific brand Dharmacon and Open Biosystems RNAi portfolios. Winning projects will be those determined by Thermo Fisher Scientific researchers to have the most scientific impact. Deadline for the grant program applications is September 7, 2009.
Award options for the grant program include microRNA libraries, RNAi gene family and whole-genome RNAi screening, in addition to RNAi Global Initiative membership, which involves 38 scientific institutions.
Thermo Fisher (NYSE: TMO) entered the RNAi market first through Fisher Scientific International Inc.’s 2004 acquisition of Colorado-based Dharmacon Inc. for $80 million. Then last year, the now-merged Thermo Fisher Scientific bought Open Biosystems Inc., an Alabama provider of RNAi products, for an undisclosed amount.
Thermo Fisher Scientific reported a net profit of $994 million on total revenue of $10.5 billion in 2008, compared to a net profit of $761 million on $9.75 billion in 2007.
RSS Feeds
Comments
Please Login/Register to post comments.
No comments have been added or approved.